In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
Immunovant Inc (NASDAQ: IMVT) closed the day trading at $20.91 up 0.53% from the previous closing price of $20.80. In other words, the price has increased by $0.53 from its previous closing price. On the day, 1.3 million shares were traded. IMVT stock price reached its highest trading level at $21.34 during the session, while it also had its lowest trading level at $20.43.
Ratios:
For a better understanding of IMVT, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.61 and its Current Ratio is at 7.61. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Oppenheimer reiterated its Outperform rating for the stock on October 09, 2024, while the target price for the stock was revised from $47 to $53.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 22 ’25 when Stout Jay S sold 2,195 shares for $23.59 per share. The transaction valued at 51,780 led to the insider holds 139,991 shares of the business.
Geffner Michael sold 2,657 shares of IMVT for $62,679 on Jan 22 ’25. The Chief Medical Officer now owns 132,314 shares after completing the transaction at $23.59 per share. On Jan 15 ’25, another insider, Macias William L., who serves as the Chief Medical Officer of the company, sold 2,383 shares for $23.83 each. As a result, the insider received 56,782 and left with 359,408 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMVT now has a Market Capitalization of 3551187200 and an Enterprise Value of 2596372736.
Stock Price History:
The Beta on a monthly basis for IMVT is 0.67, which has changed by -0.4097616 over the last 52 weeks, in comparison to a change of 0.2000997 over the same period for the S&P500. Over the past 52 weeks, IMVT has reached a high of $39.55, while it has fallen to a 52-week low of $20.48. The 50-Day Moving Average of the stock is -17.46%, while the 200-Day Moving Average is calculated to be -25.40%.
Shares Statistics:
Over the past 3-months, IMVT traded about 1.03M shares per day on average, while over the past 10 days, IMVT traded about 1319750 shares per day. A total of 146.57M shares are outstanding, with a floating share count of 68.46M. Insiders hold about 59.69% of the company’s shares, while institutions hold 46.17% stake in the company. Shares short for IMVT as of 1736899200 were 12832296 with a Short Ratio of 12.49, compared to 1734048000 on 12631893. Therefore, it implies a Short% of Shares Outstanding of 12832296 and a Short% of Float of 14.760000000000002.
Earnings Estimates
The current assessment of Immunovant Inc (IMVT) involves the perspectives of 9.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is -$0.76, with high estimates of -$0.48 and low estimates of -$0.82.
Analysts are recommending an EPS of between -$2.36 and -$3.09 for the fiscal current year, implying an average EPS of -$2.89. EPS for the following year is -$3.12, with 8.0 analysts recommending between -$2.02 and -$3.65.
